naphthazarin has been researched along with rotenone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bironaité, DA; Cénas, NK; Kulys, JJ | 1 |
| Hanif, A; Nash, JE; Perera, G; Sidorova, E; Yong-Kee, CJ | 1 |
| Lozano, AM; Monnier, PP; Nash, JE; Warre, R; Yong-Kee, CJ | 1 |
3 other study(ies) available for naphthazarin and rotenone
| Article | Year |
|---|---|
On the mechanism of rotenone-insensitive reduction of quinones by mitochondrial NADH:ubiquinone reductase. The high affinity binding of NAD+ and NADH to the reduced enzyme form.
Topics: Animals; Binding, Competitive; Cattle; Mitochondria, Heart; NAD; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; Oxidation-Reduction; Quinone Reductases; Rotenone | 1991 |
Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson's disease.
Topics: Cell Death; Cell Line, Tumor; Humans; Lysosomes; Mitochondria; Naphthoquinones; Neurons; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex; Rotenone; Time Factors; Ubiquitin | 2012 |
Evidence for synergism between cell death mechanisms in a cellular model of neurodegeneration in Parkinson's disease.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Humans; Lysosomes; Mitochondria; Naphthoquinones; Neuroblastoma; Neurotoxins; Proteasome Endopeptidase Complex; Rotenone | 2012 |